<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the antithrombotic effects of Holothuria Ldeucospilota Acidic <z:chebi fb="1" ids="37395">Mucopolysaccharide</z:chebi> (HLAM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A series of variables were observed before and after treatment with HLAM in <z:mpath ids='MPATH_458'>normal</z:mpath> middle-aged subjects and patients recovering from <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> or suffering from <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, each of which were divided into two groups according to the dosage administered (60 mg/d and 120 mg/d) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The fat metabolism was enhanced in addition to the <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and the blood viscosity reducing effects </plain></SENT>
<SENT sid="3" pm="."><plain>No side-effect was found </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: HLAM is a promising drug for antithrombotic therapy </plain></SENT>
</text></document>